HUM (Humana) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HUM Humana Inc HUM
83 GF Score
Price $386.22
GF Value $377.23
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Humana Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Humana  (NYSE:HUM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Humana Cyclically Adjusted PS Ratio Related Terms


Humana Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Humana's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humana Cyclically Adjusted PS Ratio Chart

Humana Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 0.99 0.78 0.38 0.35

Humana Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.36 0.35 0.22 0.49

HUM vs CNC, CI, MOH: Cyclically Adjusted PS Ratio Comparison

For the Healthcare Plans subindustry, Humana's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humana Cyclically Adjusted PS Ratio vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Humana's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Humana's Cyclically Adjusted PS Ratio falls into.


HUM
83GF Score
Humana Inc HUM
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Humana Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Humana's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Humana's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=337.367/333.9520*333.9520
=337.367

Current CPI (Jun. 2026) = 333.9520.

Humana Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 90.746 241.428 125.523
201612 86.120 241.432 119.122
201703 92.442 243.801 126.625
201706 92.932 244.955 126.696
201709 91.373 246.819 123.630
201712 92.571 246.524 125.401
201803 102.852 249.554 137.636
201806 102.897 251.989 136.366
201809 102.439 252.439 135.517
201812 103.018 251.233 136.937
201903 118.533 254.202 155.720
201906 119.893 256.143 156.313
201909 121.253 256.759 157.707
201912 122.333 256.974 158.979
202003 142.571 258.115 184.460
202006 143.456 257.797 185.834
202009 150.718 260.280 193.379
202012 144.306 260.474 185.014
202103 159.536 264.877 201.140
202106 159.560 271.696 196.121
202109 168.318 274.310 204.915
202112 163.212 278.802 195.497
202203 188.038 287.504 218.417
202206 186.192 296.311 209.844
202209 179.018 296.808 201.421
202212 178.592 296.797 200.949
202303 212.975 301.836 235.636
202306 213.790 305.109 234.000
202309 213.118 307.789 231.234
202312 216.085 306.746 235.250
202403 244.178 312.332 261.080
202406 244.810 314.175 260.221
202409 243.425 315.301 257.824
202412 242.522 315.605 256.620
202503 265.731 319.799 277.491
202506 268.235 322.561 277.708
202509 270.396 324.800 278.015
202512 270.195 324.054 278.448
202603 328.615 330.213 332.336
202606 337.367 333.952 337.367

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Humana (HUM) Overvalued in 2026?

Based on GuruFocus' analysis, Humana stock appears to be overvalued. The current stock price of $386.22 is trading 2.4% above its estimated GF Value™ of $377.23. GuruFocus considers Humana to be Fairly Valued.

Key valuation signals for HUM:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $377.23 vs. price of $386.22 (2.4% above fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the HUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Humana Business Description

Address 101 East Main Street, Louisville, KY, USA, 40202
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
83GF Score

Get the complete analysis for HUM

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$386.22
Price
$377.23
GF Value